Nazanin Ahmadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nazanin Ahmadi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Davood Bashash
Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication - Hamed Baghdadi
Payvand Clinical and Specialty Laboratory , Tehran , Iran
1 shared publication - Mahdi Ghorbani
Department of Medical Laboratory Sciences, School of Allied Medical Sciences AJA University of Medical Sciences Tehran Iran
1 shared publication - Mahdi Zavvar
Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Mahmoud Vahidi
Cancer Epidemiology Research Center, Aja University of Medical Sciences, Tehran, Iran
1 shared publication - Mehdi Shakouri Khomartash
Medical Biotechnology Research Center, AJA University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 1 August 2023
- Published by MDPI AG in Non-Coding RNA
- Vol. 9 (4) , 44
Long Non-Coding RNA Signatures in Lymphopoiesis and Lymphoid Malignancies
Lymphoid cells play a critical role in the immune system, which includes three subgroups of T, B, and NK cells. Recognition of the complexity of the human genetics transcriptome in lymphopoiesis has revolutionized our understanding of the regulatory potential of RNA in normal lymphopoiesis and lymphoid malignancies. Long non-coding RNAs (lncRNAs) are a class of RNA molecules greater than 200 nucleotides in length. LncRNAs have recently attracted much attention due to their critical roles in various biological processes, including gene regulation, chromatin organization, and cell cycle control. LncRNAs can also be used for cell differentiation and cell fate, as their expression patterns are often specific to particular cell types or developmental stages. Additionally, lncRNAs have been implicated in lymphoid differentiation, such as regulating T-cell and B-cell development, and their expression has been linked to immune-associated diseases such as leukemia and lymphoma. In addition, lncRNAs have been investigated as potential biomarkers for diagnosis, prognosis, and therapeutic response to disease management. In this review, we provide an overview of the current knowledge about the regulatory role of lncRNAs in physiopathology processes during normal lymphopoiesis and lymphoid leukemia.
- 1 August 2023
- Published by MDPI AG in Non-Coding RNA
- Vol. 9 (4) , 44
Open AccessLong Non-Coding RNA Signatures in Lymphopoiesis and Lymphoid Malignancies
Lymphoid cells play a critical role in the immune system, which includes three subgroups of T, B, and NK cells. Recognition of the complexity of the human genetics transcriptome in lymphopoiesis has revolutionized our understanding of the regulatory potential of RNA in normal lymphopoiesis and lymphoid malignancies. Long non-coding RNAs (lncRNAs) are a class of RNA molecules greater than 200 nucleotides in length. LncRNAs have recently attracted much attention due to their critical roles in various biological processes, including gene regulation, chromatin organization, and cell cycle control. LncRNAs can also be used for cell differentiation and cell fate, as their expression patterns are often specific to particular cell types or developmental stages. Additionally, lncRNAs have been implicated in lymphoid differentiation, such as regulating T-cell and B-cell development, and their expression has been linked to immune-associated diseases such as leukemia and lymphoma. In addition, lncRNAs have been investigated as potential biomarkers for diagnosis, prognosis, and therapeutic response to disease management. In this review, we provide an overview of the current knowledge about the regulatory role of lncRNAs in physiopathology processes during normal lymphopoiesis and lymphoid leukemia.